Prostate-specific antigen and related isoforms in the diagnosis and management of prostate cancer. by Haese, A, Graefen, M, Huland, H, Lilja, H

[Isoforms of free prostate-specific antigen] by Haese, A, Noldus, J, Steuber, T, Huland, H, Lilja, H

Isoforms of free prostate-specific antigen by Haese, A, Noldus, J, Steuber, T, Huland, H, Lilja, H

Discrimination of prostate cancer from benign disease by selective measurements of serum subfractions of free PSA that are not internally cleaved at Lys145-Lys146 by Nurmikko, P, Steuber, T, Haese, A, Pettersson, K, Hammerer, P, Huland, H, Lilja, H

Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer. by Haese, A, Becker, C, Noldus, J, Graefen, M, Huland, E, Huland, H, Lilja, H

Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen. by Steuber, T, Nurmikko, P, Haese, A, Pettersson, K, Graefen, M, Hammerer, P, Huland, H, Lilja, H

Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy. by Steuber, T, Vickers, A, Haese, A, Kattan, M, Eastham, J, Scardino, P, Huland, H, Lilja, H

Inhibition of dendropoiesis by tumor derived and purified prostate specific antigen. by Aalamian, M, Tourkova, I, Chatta, G, Lilja, H, Huland, E, Huland, H, Shurin, G, Shurin, MR

Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml. by Haese, A, Graefen, M, Steuber, T, Becker, C, Pettersson, K, Piironen, T, Noldus, J, Huland, H, Lilja, H

Enhanced discrimination of benign from malignant prostatic disease by selective measurements of cleaved forms of urokinase receptor in serum. by Piironen, T, Haese, A, Huland, H, Steuber, T, Christensen, I, Brünner, N, Danø, K, Høyer-Hansen, G, Lilja, H

Total and gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in ser... by Haese, A, Graefen, M, Steuber, T, Becker, C, Noldus, J, Erbersdobler, A, Huland, E, Huland, H, Lilja, H

Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in ser... by Haese, A, Graefen, M, Steuber, T, Becker, C, Noldus, J, Erbersdobler, A, Huland, E, Huland, H, Lilja, H

Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer. by Steuber, T, Vickers, A, Serio, A, Vaisanen, V, Haese, A, Pettersson, K, Eastham, J, Scardino, P, Huland, H, Lilja, H

Prediction of tumor heterogeneity in localized prostate cancer. by Huland, H, Graefen, M, Haese, A, Hammerer, P, Palisaar, J, Pichlmeier, U, Henke, R, Erbersdobler, A, Huland, E, Lilja, H

Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined wit... by Haese, A, Vaisanen, V, Lilja, H, Kattan, M, Rittenhouse, H, Pettersson, K, Chan, D, Huland, H, Sokoll, L, Partin, A

Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue. by Steuber, T, Niemela, P, Haese, A, Pettersson, K, Erbersdobler, A, Felix Chun, K, Graefen, M, Kattan, M, Huland, H, Lilja, H

Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific anti... by Steuber, T, Vickers, A, Haese, A, Becker, C, Pettersson, K, Chun, F, Kattan, M, Eastham, J, Scardino, P, Huland, H, Lilja, H

The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer. by Haese, A, Graefen, M, Becker, C, Noldus, J, Katz, J, Cagiannos, I, Kattan, M, Scardino, P, Huland, E, Huland, H, Lilja, H

Upregulation of centromere protein F is linked to aggressive prostate cancers by Göbel C, Özden C, Schroeder C, Hube-Magg C, Kluth M, Möller-Koop C, Neubauer E, Hinsch A, Jacobsen F, Simon R, Sauter G, Michl U, Pehrke D, Huland H, Graefen M, Schlomm T, Luebke AM

Get full text

Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and associa... by Helo, P, Cronin, A, Danila, D, Wenske, S, Gonzalez-Espinoza, R, Anand, A, Koscuiszka, M, Väänänen, R, Pettersson, K, Chun, F, Steuber, T, Huland, H, Guillonneau, B, Eastham, J, Scardino, P, Fleisher, M, Scher, H, Lilja, H